Bioactivity:

CL2A is a claevable complicated PEG8- and triazole-containing PABC-peptide-mc linker. CL2A is cleavable through pH sensitivity, giving rise to bystander effect, and binds the antibody at a cysteine residue via a disulfide bond. Labetuzumab govitecan used

CAS nr:

1846605-04-6

Purity:

98%

Molecular Weight:

1106,22

SMILES:

O=C(NC1=CC=C(COC(O)=O)C=C1)[C@H](CCCCN)NC(COCC(NCCOCCOCCOCCOCCOCCOCCOCCOCCN2N=NC(CNC(C3CCC(CN4C(C=CC4=O)=O)CC3)=O)=C2)=O)=O

Formula:

C51H79N9O18

Pathway:

Others

Target:

Others